• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

长链非编码RNA ASB16-AS1作为miR-760的海绵，通过增加HDGF表达促进骨肉瘤的恶性表型[撤回]

Long Non-Coding RNA ASB16-AS1 Functions as a miR-760 Sponge to Facilitate the Malignant Phenotype of Osteosarcoma by Increasing HDGF Expression [Retraction].

出版信息

Onco Targets Ther. 2021 Sep 9;14:4743-4744. doi: 10.2147/OTT.S337586. eCollection 2021.

DOI:10.2147/OTT.S337586
PMID:34526780
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8437386/
Abstract

[This retracts the article DOI: 10.2147/OTT.S240022.].

摘要

[本文撤回文章DOI: 10.2147/OTT.S240022。]

相似文献

1
Long Non-Coding RNA ASB16-AS1 Functions as a miR-760 Sponge to Facilitate the Malignant Phenotype of Osteosarcoma by Increasing HDGF Expression [Retraction].长链非编码RNA ASB16-AS1作为miR-760的海绵，通过增加HDGF表达促进骨肉瘤的恶性表型[撤回]
Onco Targets Ther. 2021 Sep 9;14:4743-4744. doi: 10.2147/OTT.S337586. eCollection 2021.
2
Long Non-Coding RNA ASB16-AS1 Functions as a miR-760 Sponge to Facilitate the Malignant Phenotype of Osteosarcoma by Increasing HDGF Expression.长链非编码RNA ASB16-AS1作为miR-760的海绵，通过增加HDGF表达促进骨肉瘤的恶性表型。
Onco Targets Ther. 2020 Mar 13;13:2261-2274. doi: 10.2147/OTT.S240022. eCollection 2020.
3
Long non-coding RNA ASB16-AS1 enhances cell proliferation, migration and invasion via functioning as a ceRNA through miR-1305/Wnt/β-catenin axis in cervical cancer.长链非编码 RNA ASB16-AS1 通过作为 ceRNA 通过 miR-1305/Wnt/β-连环蛋白轴在宫颈癌中增强细胞增殖、迁移和侵袭。
Biomed Pharmacother. 2020 May;125:109965. doi: 10.1016/j.biopha.2020.109965. Epub 2020 Feb 10.
4
Long Noncoding RNA CCDC144NL-AS1 Promotes the Oncogenicity of Osteosarcoma by Acting as a Molecular Sponge for microRNA-490-3p and Thereby Increasing HMGA2 Expression [Retraction].长链非编码RNA CCDC144NL-AS1通过充当微小RNA-490-3p的分子海绵从而增加HMGA2表达来促进骨肉瘤的致癌性[撤回]
Onco Targets Ther. 2023 Jul 13;16:577-578. doi: 10.2147/OTT.S430211. eCollection 2023.
5
ASB16-AS1 up-regulated and phosphorylated TRIM37 to activate NF-κB pathway and promote proliferation, stemness, and cisplatin resistance of gastric cancer.ASB16-AS1 上调并磷酸化 TRIM37，激活 NF-κB 通路，促进胃癌的增殖、干性和顺铂耐药性。
Gastric Cancer. 2021 Jan;24(1):45-59. doi: 10.1007/s10120-020-01096-y. Epub 2020 Jun 22.
6
The Long Non-Coding RNA SBF2-AS1 Exerts Oncogenic Functions in Gastric Cancer by Targeting the miR-302b-3p/E2F Transcription Factor 3 Axis [Retraction].长链非编码RNA SBF2-AS1通过靶向miR-302b-3p/E2F转录因子3轴在胃癌中发挥致癌作用[撤回]
Onco Targets Ther. 2020 Mar 26;13:2523. doi: 10.2147/OTT.S254587. eCollection 2020.
7
Long Non-Coding RNA HAND2-AS1 Inhibits Growth and Migration of Gastric Cancer Cells Through Regulating the miR-590-3p/KCNT2 Axis [Retraction].长链非编码RNA HAND2-AS1通过调控miR-590-3p/KCNT2轴抑制胃癌细胞的生长和迁移[撤回]
Onco Targets Ther. 2021 Oct 4;14:4997-4998. doi: 10.2147/OTT.S341753. eCollection 2021.
8
Long non-coding RNA AGAP2-AS1 promotes the proliferation of glioma cells by sponging miR-15a/b-5p to upregulate the expression of HDGF and activating Wnt/β-catenin signaling pathway.长链非编码 RNA AGAP2-AS1 通过海绵吸附 miR-15a/b-5p 来上调 HDGF 的表达，从而激活 Wnt/β-catenin 信号通路，促进神经胶质瘤细胞的增殖。
Int J Biol Macromol. 2019 May 1;128:521-530. doi: 10.1016/j.ijbiomac.2019.01.121. Epub 2019 Jan 23.
9
Long noncoding RNA ASB16-AS1 inhibits adrenocortical carcinoma cell growth by promoting ubiquitination of RNA-binding protein HuR.长链非编码 RNA ASB16-AS1 通过促进 RNA 结合蛋白 HuR 的泛素化来抑制肾上腺皮质癌细胞生长。
Cell Death Dis. 2020 Nov 20;11(11):995. doi: 10.1038/s41419-020-03205-2.
10
LncRNA ASB16-AS1 Promotes Growth and Invasion of Hepatocellular Carcinoma Through Regulating miR-1827/FZD4 Axis and Activating Wnt/β-Catenin Pathway [Retraction].长链非编码RNA ASB16-AS1通过调控miR-1827/FZD4轴及激活Wnt/β-连环蛋白通路促进肝细胞癌的生长和侵袭[撤回]
Cancer Manag Res. 2022 Feb 10;14:501-502. doi: 10.2147/CMAR.S361002. eCollection 2022.